Chinese medical device manufacturers are increasingly looking to European markets for growth as domestic anti-corruption campaigns impact sales. Companies like Jenscare Scientific, a heart medical device maker, are seeking CE certification under the EU's Medical Device Regulation to facilitate sales across the region. This strategic shift is driven by a reported 12% year-on-year decrease in government-backed hospital purchases in China during the first five months of 2026, affecting the revenue of major domestic players. AI
RANK_REASON Significant international market expansion by Chinese companies driven by domestic policy changes. [lever_c_demoted from significant: ic=1 ai=0.1]
- China
- Europe
- European Union
- Hong Kong
- HSBC
- Jenscare Scientific
- Linda Shuttle
- LuX-Valve Plus
- Medical Device Regulation
- Ningbo
- Zhejiang
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →